Oral Azacitidine Maintenance After CPX‐351 in Transplant‐Ineligible Patients With Therapy‐Related or Myelodysplasia‐Related Acute Myeloid Leukemia

Caroline Fileni, Edmond Chiche, David Swoboda, Alexander Coltoff, Rami Komrokji, Geoffrey Uy, Sarah Bertoli, Lenaig Le Clech, Mael Heiblig, Ludovic Gabellier, Patrick Lawrence, Lydia Kretschmer, Christoph Röllig, A. H. Wei, Fabio Guolo, Roberto Massimo Lemoli, Jeffrey Lancet, David Sallman, Thomas Cluzeau
American Journal of Hematology · Wiley · 2026-10-09 · DOI: 10.1002/ajh.70521

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles